Cargando…
mTOR Signaling Pathway in Cancer Targets Photodynamic Therapy In Vitro
The Mechanistic or Mammalian Target of Rapamycin (mTOR) is a major signaling pathway in eukaryotic cells belonging to the P13K-related kinase family of the serine/threonine protein kinase. It has been established that mTOR plays a central role in cellular processes and implicated in various cancers,...
Autores principales: | Ayuk, Sandra M., Abrahamse, Heidi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563036/ https://www.ncbi.nlm.nih.gov/pubmed/31075885 http://dx.doi.org/10.3390/cells8050431 |
Ejemplares similares
-
mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
por: Tian, Tian, et al.
Publicado: (2019) -
mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020) -
Theranostic imaging and multimodal photodynamic therapy and immunotherapy using the mTOR signaling pathway
por: Zhou, Huiling, et al.
Publicado: (2023) -
Targeting mTOR for cancer therapy
por: Hua, Hui, et al.
Publicado: (2019) -
The mTOR Signalling Pathway in Human Cancer
por: Pópulo, Helena, et al.
Publicado: (2012)